Published in J Am Acad Dermatol on February 01, 2006
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study. BMJ (2010) 1.18
Melanoma in immunosuppressed patients. Mayo Clin Proc (2012) 1.07
Dermatoscopy, not dermoscopy! J Am Acad Dermatol (2006) 0.93
A case with postchemotherapy eruptive compound nevus. Indian J Dermatol (2011) 0.75
Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol (2005) 3.18
The cost effectiveness of biologic therapy for the treatment of chronic plaque psoriasis in real practice settings in Italy. BioDrugs (2014) 1.99
Dermoscopic changes in melanocytic naevi in children during digital follow-up. Acta Derm Venereol (2012) 1.99
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol (2006) 1.70
Skin cancer and other cutaneous disorders in liver transplant recipients. Acta Derm Venereol (2012) 1.41
Vohwinkel syndrome: treatment of pseudo-ainhum. Int J Dermatol (2010) 1.15
Immunosuppression and melanocyte proliferation. Melanoma Res (2009) 1.12
Bullous pemphigoid during long-term TNF-alpha blocker therapy. Dermatology (2009) 1.03
A case of malignant melanoma arising from an acquired agminated melanocytic naevus. Acta Derm Venereol (2007) 1.02
Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. Am J Transplant (2004) 0.95
Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review. Autoimmun Rev (2008) 0.94
Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol (2004) 0.92
Current patch test results with the European baseline series and extensions to it from the 'European Surveillance System on Contact Allergy' network, 2007-2008. Contact Dermatitis (2012) 0.92
Primary cutaneous mantle cell lymphoma. Acta Derm Venereol (2011) 0.91
Risk factors of hypertension, diabetes and obesity in Italian psoriasis patients: a survey on socio-demographic characteristics, smoking habits and alcohol consumption. Eur J Dermatol (2009) 0.89
Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review. Acta Derm Venereol (2009) 0.87
The European baseline series in 10 European Countries, 2005/2006--results of the European Surveillance System on Contact Allergies (ESSCA). Contact Dermatitis (2009) 0.87
Nickel, cobalt and chromate sensitization and occupation. Contact Dermatitis (2010) 0.87
Quality of life assessment of patients with scalp dermatitis using the Italian version of the Scalpdex. Acta Derm Venereol (2014) 0.87
Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol (2010) 0.86
Impaired coronary flow reserve in young patients affected by severe psoriasis. Atherosclerosis (2011) 0.85
Occurrence of squamous cell carcinoma in an area of lichen simplex chronicus: case report and pathogenetic hypothesis. J Cutan Med Surg (2012) 0.85
Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study. Dermatology (2008) 0.84
The role of immunohistochemical analysis in the diagnosis of parapsoriasis. Acta Histochem (2010) 0.84
Targeting DSG3: from pemphigus to squamous cell carcinoma. Expert Opin Ther Targets (2013) 0.84
Imiquimod for the treatment of classical Kaposi's sarcoma. Acta Derm Venereol (2010) 0.84
Contact sensitization in very young children. J Am Acad Dermatol (2011) 0.84
Cost-effectiveness analysis of TNF-alpha blockers for the treatment of chronic plaque psoriasis in the perspective of the Italian health-care system. Dermatol Ther (2010) 0.84
Facial basal cell carcinoma: analysis of recurrence and follow-up strategies. Oncol Rep (2011) 0.83
Bullous scabies simulating pemphigoid. J Cutan Med Surg (2011) 0.83
Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis. Immunopharmacol Immunotoxicol (2012) 0.83
Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with absence of desmoglein 1 and 3 antibodies: case report and literature review. Am J Clin Dermatol (2008) 0.82
Occupational sensitization to epoxy resins in Northeastern Italy (1996-2010). Int J Occup Environ Health (2015) 0.82
Effectiveness of different substrate materials for in vitro sunscreen tests. J Dermatol Sci (2009) 0.82
Incidence and clinical predictors of Kaposi's sarcoma among 1721 Italian solid organ transplant recipients: a multicenter study. Eur J Dermatol (2006) 0.81
Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up. Clin Dev Immunol (2009) 0.81
Allergic contact sensitivity in elderly patients. Aging Clin Exp Res (2004) 0.81
Biochip technology for the serological diagnosis of bullous pemphigoid. ISRN Dermatol (2012) 0.81
Nevus spilus and melanoma: case report and review of the literature. J Cutan Med Surg (2010) 0.81
Large plaque type blue nevus with subcutaneous cellular nodules. Eur J Dermatol (2009) 0.81
Melanoma in skin affected with keratoderma palmoplantaris hereditaria (Mal de Meleda): Treatment with excision and grafting. J Am Acad Dermatol (2009) 0.81
Successful treatment of Melkersson-Rosenthal Syndrome with lymecycline. Eur J Dermatol (2004) 0.80
Verrucous cutaneous sarcoidosis in an adolescent with dark skin. Eur J Dermatol (2010) 0.80
p-Phenylenediamine sensitization and occupation. Contact Dermatitis (2010) 0.80
Expression of the CD1a molecule in B- and T-lymphoproliferative skin conditions. Oncol Rep (2006) 0.80
Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma. Cancer (2002) 0.79
C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients. Transpl Int (2005) 0.79
Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients. Exp Dermatol (2006) 0.79
Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. BMC Dermatol (2009) 0.78
Sunscreen tests: correspondence between in vitro data and values reported by the manufacturers. J Dermatol Sci (2008) 0.78
Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation. Mutat Res (2009) 0.78
Melanoma m (zero): diagnosis and therapy. ISRN Dermatol (2013) 0.78
Skin disorders in patients transplanted in childhood. Transpl Int (2005) 0.77
Italian Euromelanoma Day Screening Campaign (2005-2007) and the planning of melanoma screening strategies. Eur J Cancer Prev (2012) 0.77
Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial. J Dermatolog Treat (2007) 0.77
Perception of disease and doctor-patient relationship experienced by patients with psoriasis: a questionnaire-based study. Am J Clin Dermatol (2009) 0.77
In vitro evaluation of sunscreens: an update for the clinicians. ISRN Dermatol (2012) 0.77
Erosive pustular dermatosis of the scalp induced by imiquimod. Case Rep Dermatol Med (2012) 0.77
Melanoma m1: diagnosis and therapy. In Vivo (2014) 0.77
Non-alcoholic fatty liver disease, alcohol intake and psoriasis. J Hepatol (2010) 0.77
CD7 expression in reactive and malignant human skin T-lymphocytes. Anticancer Res (2003) 0.76
γδ T cells as potential contributors to the progression of parapsoriasis to mycosis fungoides. Mol Med Rep (2011) 0.76
Melanoma and immunosuppression. Dermatology (2008) 0.76
Achromic superficial spreading melanoma accidentally treated with imiquimod. Acta Derm Venereol (2012) 0.76
Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study. Thromb Haemost (2015) 0.76
Differential management of mild-to-severe psoriasis with biologic drugs: An Italian Delphi consensus expert panel. J Dermatolog Treat (2014) 0.76
Erythroderma in the era of biological therapies. Eur J Dermatol (2012) 0.75
An unusual association between erosive hand osteoarthritis and morphea. Joint Bone Spine (2011) 0.75
Long-term Survival of Patients With Invasive Ultra-thin Cutaneous Melanoma: A Single-center Retrospective Analysis. Medicine (Baltimore) (2016) 0.75
Adaptive immune responses in primary cutaneous sarcoidosis. Clin Dev Immunol (2011) 0.75
Clinical and dermoscopic features of nevi in preschool children in Padua. Dermatology (2009) 0.75
Response to “change in dermoscopic pattern of naevi in children” by Scope et al. Acta Derm Venereol (2014) 0.75
A Case of Angioinvasive Cutaneous Anaplastic Large Cell Lymphoma Completely Regressed After Low-dose Systemic Methotrexate. Acta Derm Venereol (2017) 0.75
Rejection-mediated regression of melanocytic naevi in an immunosuppressed organ transplant recipient. Acta Derm Venereol (2014) 0.75
Pustular eruption associated with granulocyte colony-stimulating factor treatment. G Ital Dermatol Venereol (2016) 0.75
Exacerbation of a Primary Follicular Centre Cutaneous B-cell Lymphoma during Pregnancy and Resolution to Anetoderma After Delivery. Acta Derm Venereol (2016) 0.75
Eczematous, Pruritic, Brownish Plaque of the Nipple and Areola: A Quiz. Acta Derm Venereol (2019) 0.75